Save time and get answers to complex questions with AI chat
Tenofovir generic patent?Patent expiration eu dabrafenib?Novartis patent term dabrafenib?Xenazine current manufacturer 2025?Pramlintide approval date?
See the DrugPatentWatch profile for Sulfasalazine
Sulfasalazine is a disease-modifying anti-rheumatic drug (DMARD) that belongs to the sulfonamide class of medications (an aminosalicylate/sulfa drug used mainly for inflammatory bowel disease and inflammatory arthritis) [1].
Sulfasalazine is commonly prescribed for: - Ulcerative colitis and Crohn’s disease (especially for mild-to-moderate flare control and maintenance in ulcerative colitis). - Rheumatoid arthritis and other inflammatory arthritis conditions (it is used as a DMARD) [1].
No. Despite containing a “sulfa” (sulfonamide) component, sulfasalazine is not used as an antibiotic. Its clinical use is as an anti-inflammatory DMARD/aminosalicylate agent for immune-driven diseases [1].
Sulfasalazine is often grouped with other “5-ASA” (aminosalicylate) or sulfonamide/anti-inflammatory options used in similar GI and inflammatory contexts, though the exact class varies by specific product and indication [1].
[1] https://www.drugs.com/sulfasalazine.html
Other Questions About Sulfasalazine :